Adoptive cell therapy for Melanoma using tumour infiltrating lymphocytes: John Bridgeman
23 Mga view
• 07/30/23
0
0
I-embed
administrator
Mga subscriber
A look at the use of TIL in Melanoma and future TIL engineering strategies. John Bridgeman is the Director of Cell Therapy Research at Immetacyte Ltd
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento